Sirona Biochem Corp.
SRBCF · OTC
7/31/2024 | 4/30/2024 | 1/31/2024 | 10/31/2023 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | -$0 |
| % Growth | -77% | 604.8% | 105% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | -$0 | -$0 |
| % Margin | 100% | 77.8% | -52.8% | 108.1% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1 | $1 | $1 | $1 |
| Operating Income | -$1 | -$0 | -$1 | -$1 |
| % Margin | -25,781.2% | -3,430.2% | -45,285.8% | 1,811.2% |
| Other Income/Exp. Net | -$0 | $0 | -$0 | -$0 |
| Pre-Tax Income | -$1 | -$1 | -$1 | -$1 |
| Tax Expense | $0 | -$0 | $0 | $0 |
| Net Income | -$1 | -$0 | -$1 | -$1 |
| % Margin | -34,808.5% | -3,774.6% | -46,588.9% | 2,000.9% |
| EPS | -0.003 | -0.002 | -0.003 | -0.003 |
| % Growth | -112.5% | 44.8% | -16% | – |
| EPS Diluted | -0.003 | -0.002 | -0.003 | -0.003 |
| Weighted Avg Shares Out | 259 | 254 | 254 | 254 |
| Weighted Avg Shares Out Dil | 259 | 254 | 254 | 254 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$1 | -$0 | -$1 | -$1 |
| % Margin | -26,035.5% | -3,784.3% | -41,693% | 1,791.2% |